Letter to the editor

Affiliations

Comment

Adriano Arguedas et al. Vaccine. 2019.

. 2019 Dec 10;37(52):7530-7531.

doi: 10.1016/j.vaccine.2019.09.107.

¹ Pfizer Inc, Collegeville, PA, USA. Electronic address: adriano.arguedas@pfizer.com.
² Pfizer Inc, Collegeville, PA, USA.

No abstract available

Comment in

Authors' reply to: Letter from Arguedas et al.
Kim MJ, Kim JH, Chun BC, Yang KS. Kim MJ, et al. Vaccine. 2019 Dec 10;37(52):7532-7533. doi: 10.1016/j.vaccine.2019.09.110. Vaccine. 2019. PMID: 31783979 No abstract available.

Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.
Kim JH, Chun BC, Song JY, Kim HY, Bae IG, Kim DM, Choi YH, Jun YH, Choi WS, Kang SH, Kwon HH, Jeong HW, Kee SY, Hur J, Chung JW, Yoon YK, Sohn JW, Yang KS, Kim MJ. Kim JH, et al. Vaccine. 2019 May 9;37(21):2797-2804. doi: 10.1016/j.vaccine.2019.04.017. Epub 2019 Apr 17. Vaccine. 2019. PMID: 31005428